Concepedia

Poulabi Banerjee

PB

Statistics

Publications

26

Citations

3.6K

H-Index

20

Active since

1997

Affiliations

Regeneron (United States)(Current)

Sanofi (France)

Icahn School of Medicine at Mount Sinai

University of Pennsylvania

Université de Montréal

Poulabi Banerjee is an author at Regeneron (United States) specializing in medicine, genetics, and atherosclerosis.

ORCID

Top concepts

Publications per year

1997–2024

26

Publications

26

Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease

Frederick E. Dewey, Viktoria Gusarova, Richard L. Dunbar et al. · New England Journal of Medicine · 2017 · 836 citations · Full text

Evinacumab for Homozygous Familial Hypercholesterolemia

Frederick J. Raal, Robert S. Rosenson, Laurens F. Reeskamp et al. · New England Journal of Medicine · 2020 · 707 citations · Full text

Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia

Zahid Ahmad, Poulabi Banerjee, Sara Hamon et al. · Circulation · 2019 · 235 citations · Full text

Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial

Amy Damask, Philippe Gabríel Steg, Gregory G. Schwartz et al. · Circulation · 2019 · 232 citations · Full text

An association study of 43 SNPs in 16 candidate genes with atorvastatin response

John F. Thompson, M. Man, Keith Johnson et al. · The Pharmacogenomics Journal · 2005 · 213 citations

, , +11

1–5 of 26